Ozempic and Wegovy maker courts prominent Black leaders to get Medicare's favor
Drugmaker Novo Nordisk focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease — worth treating at a cost of $1,000 or more a month. #press
